U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 5100138

Motorized Mobile Boxing Robot

A simulation environment for the sport of boxing utilizing a robotic machine interface system which carries a person.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 540/607 - Having -C(=X)-, wherein X is chalcogen, bonded directly to nitrogen of the hetero ring


Subclass of Class 540 - Organic compounds -- part of the class 532-570 series
Definition: Compounds in which- - wherein X is chalcogen (i.e., oxygen,
No. of patents: 172
Last issue date: 11/06/2007


1          
NumberTitleIssue Date
7291738Therapeutic compounds
The present invention provides compounds, for example, of formula (I): wherein R1, R2, and R3 have any of the values defined in the specification, as well as pharmaceutical compos...
11/06/2007
7285547Amidinophenylalanine derivatives as thrombin inhibitors
The compounds of the formula (formula 1) and pharmaceutically acceptable salts thereof and a process for preparing the same and pharmaceutical compositions containing the same are described wherein the substituents have the meaning as specified in the description. T...
10/23/2007
7241902Allylmercaptocaptopril compounds and uses thereof
Compounds which are the reaction product of allicin and ACE-inhibiting compounds are useful in treating hypertension, elevated triglycerides, and elevated insulin. ...
07/10/2007
7138547Antitumoral compounds
New spisulosine derivatives of use in treating tumors are of the formula (I) wherein: each X is the same or different, and represents H, OH, OR′, SH, SR′, SOR′, SO2R′, NO2, NH2, NHR′, N(R′)2, CN, halogen, C(═...
11/21/2006
6927290Production of mixed acid anhydride and amide compound
There is disclosed an advantageous mixed acid anhydride production method of formula (1): R1C(O)OY(O)n(R2)p  (1) wherein R1, R2 and Y denote the same as defined below, n and p ...
08/09/2005
6921822Process for stereoselectively reducing 4-aryl-4-oxobutanoic acid derivatives
The present invention relates to a process for preparing stereoisomerically enriched 4-aryl-4-hydroxybutanoic acid derivatives by reducing 4-aryl-4-ketobutanoic acid derivatives in the presence of ruthenium-containing catalysts. ...
07/26/2005
6887866Short-acting sedative hypnotic agents for anesthesia and sedation
The invention provides compounds compositions and methods useful for inducing or maintaining general anesthesia or sedation in mammals. ...
05/03/2005
6887864Azepane derivatives
This invention provides novel azepane derivatives or pharmaceutically acceptable salts thereof, according to the general formula (I) wherein the symbols are defined in the specification, as well as processes for their ...
05/03/2005
6855706Phenylalanine derivatives
Specified phenylalanine derivatives and analogues thereof have an antagonistic activity to α 4 integrin. They are used as therapeutic agents for various diseases concerning α 4 integrin. ...
02/15/2005
6835831Diastereoselective synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
Disclosed is a method of preparing a composition comprising a compound represented Structural Formula (I): The method comprises the step of reacting an aldehyde compound R10CHO with an isonitrile compound re...
12/28/2004
6790978Thyromimetic organic compounds
Compounds of the present invention of the formula are thyromimetic agents which can be used to prevent and/or treat diseases associated with an imbalance of thyroid hormones, such as hypo- and hyper-thyroidism, obesity, ...
09/14/2004
6677354Piperdines for use as orexin receptor antagonists
Disclosed are compounds of formula (I): ##STR1## wherein: Y represents a group (CH2)n, wherein n represents 0, 1 or 2; R1 is phenyl, naphthyl, a mono or bicyclic heteroaryl group containing up to 3 heteroatoms selected ...
01/13/2004
6653472Preparing amidines derived from 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid
New intermediates of the formula (II)B described below for the synthesis of amidine derivatives of (-)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid, such as for example (S)-N-{4-[4-[(3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyra...
11/25/2003
66028251-Aryl-1,3,5-triazine-4-thione-2,6-diones, production thereof and use thereof as herbicides
Novel 1-aryl-4-thiotriazines I ##STR1## where the variables have the following meanings: R1 =H, NH2, C1 -C4 -alkyl, C1 -C4 -haloalkyl; R2 =H, NH2, C1 -C4 -...
08/05/2003
6544986Pyridones and their use as modulators of serine hydrolase enzymes
This invention relates to a compound of formula I: ##STR1## or a pharmaceutically acceptable salt thereof; in which preferably R3, R4 and R6 are each hydrogen; X is C.dbd.O or CH2 ; and R7 and R8 are...
04/08/2003
6534536Alkylsulfonamido heterocyclic thrombin inhibitors
Alkylsulfonamido heterocyclic thrombin inhibitors are provided which have the structure ##STR1## wherein G is ##STR2## wherein n is 0, 1 or 2 or 3; m is 0, 1, 2 or 3; Y is NH or S; R is hydrogen, hydroxyalkyl, aminoalkyl, alkyl, cycloalkyl, amidoalkyl, ...
03/18/2003
6451824Sulfonylaminocarboxylic acids
Compounds of formula (I) ##STR1## are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading metalloproteinases is involved....
09/17/2002
6423689Peptidyl calcium channel blockers
The present invention provides compounds that block calcium channels having the Formula I shown below. ##STR1## The present invention also provides methods of using the compounds of Formula I to treat stroke, cerebral ischemia, head trauma, or epilepsy an...
07/23/2002
6362174Reduced dipeptide analogues as calcium channel antagonitsts
The present invention provides novel N-type calcium channel blockers, compositions comprising them, and methods of their use. The compounds of the invention are useful in the treatment of stroke, cerebral ischemia, pain, epilepsy, and head trauma. The nov...
03/26/2002
6344466Benzamide and sulfonamide substitued aminoguanidines and alkoxyguanidines as protease inhibitors
The present invention is directed to aminoguanidine and alkoxyguanidine compounds, including compounds of Formula I: ##STR1## wherein X is O or NH, L is --O-- or --SO2 --, and R1 -R4, R9 -R19, Ra...
02/05/2002
6337394Compounds
There is provided compounds of formula I, ##STR1## wherein R1, R2, R3, Rx, Y, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases, such as thrombin...
01/08/2002
6316440Reduced dipeptide analogues as calcium channel antagonists
##STR1## The present invention provides novel N-type calcium channel blockers, compositions comprising them, and methods of their use. The compounds of the invention are useful in the treatment of stroke, cerebral ischemia, pain, epilepsy, and head trauma...
11/13/2001
6310246Fluorovinloxyacetamides, process for preparing same and herbicidal composition comprising same
Herbicidal fluorovinyloxyacetamide compounds of formula (I) are useful for protecting crops from weeds: ##STR1## wherein: R1 is a phenyl group optionally having one or more substituents selected from the group consisting of C1-6 alky...
10/30/2001
6251949Oxime derivatives, hydrazone derivatives and use thereof
Compounds having fungicidal activities and represented by general formula (I) and salts and hydrates thereof ##STR1## wherein R1 represents an optionally substituted aryl, an optionally substituted alkyl or the like; R2 represents an...
06/26/2001
6201126Isoindolenineamide dyestuffs
Compounds of the formula (I) ##STR1## in which A represents N or a cyanomethylene radical, B represents S, O or NH and R1, R2, R3 and x have the meaning given in the description, are highly suitable for dyeing and printing high...
03/13/2001
5945543Process for producing ଱-(N,N dialkyl)-amino carboxlic acid amides
A process for preparing ଱-(N,N-dialkylamino) carboxamides of the formula I ##STR1## where the substituents have the stated meanings, comprises reacting the corresponding free acids with primary or secondary amines in the presence of anhydr...
08/31/1999
5939437CCK and gastrin receptor ligands
Compounds of formula (I) and their pharmaceutically active salts are gastrin and CCK receptor ligands, where Ar is a monocyclic aromatic group, R1 is halo, amino, nitro, cyano, sulphamoyl, sulphonyl, trifluoromethyl, C1 to C3
08/17/1999
5917034Antithrombotic n-amidinopiperidine and benzamidine derivatives
Compounds of formula (I), pharmaceutically acceptable salts thereof, and pharmaceutically acceptable solvates of either entity, wherein A is optionally monosaturated C1 -C4 alkylene optionaly monounsaturatred with C1 -C
06/29/1999
5891876Heteroatom substituted benzoyl derivatives that enhance synaptic responses mediated by AMPA receptors
Compounds useful for enhancing synaptic responses mediated by AMPA receptors are disclosed, as are methods for the preparation thereof, and methods for their use for treatment of subjects suffering from impaired nervous or intellectual functioning due to ...
04/06/1999
5859002HIV protease inhibitors
HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain the...
01/12/1999
5856318Nitrogen-containing cyclohetero cyclo-heteroaminoaryl derivatives for CNS disorders
Certain nitrogen-containing cyclohetero cycloalkylaminoaryl compounds are described for treatment of CNS disorders such as cerebral ischemia, psychoses and convulsions. Compounds of particular interest are of the formula: ##STR1## wherein each o...
01/05/1999
5852008Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors
Compounds having the following structural formula, ##STR1## are useful for enhancing synaptic response mediated by AMPA receptors are disclosed, the invention compounds can also be used for the treatment of non-impaired subject for enhancing performa...
12/22/1998
5846979N-oxides of heterocyclic esters, amides, thioesters, and ketones
This invention relates to neurotrophic low molecular weight, small molecule N-oxides of heterocyclic esters, amides, thioesters, and ketones having an affinity for FKBP-type immunophilins, and their use as inhibitors of the enzyme activity associated with...
12/08/1998
58471591-›ω-(3,4-dihydro-2-naphthalenyl)alkyl!-cyclic amine derivatives, process for preparing the same, and pharmaceutical composition containing the same
1-›ω-(3,4-Dihydro-2-naphthalenyl)alkyl!cyclic amine derivative of the formula (I): ##STR1## wherein R1 and R2 are H, halogen, OH, alkyl, alkoxy, hydroxymethyl, etc., or R1 and R2 combine to form meth...
12/08/1998
5741799Heterocyclic thrombin inhibitors
Heterocyclic thrombin inhibitors are provided which have the structure ##STR1## wherein n, R, R1, R2, R3, G, Gx, R6', Ra, Xa, R6, Rb, R3, p, Q, A and R4 are as defined...
04/21/1998
5741792Heterocyclic thrombin inhibitors
Heterocyclic thrombin inhibitors are provided which have the structure ##STR1## wherein n, R, R1, R2, R3, G, Gx, R6 ', Ra, Xa, R6, Rb, R3, p, Q, A and R4 are as define...
04/21/1998
5693630Phenylethyl and phenylpropylamines
Compounds of the general formula ##STR1## or pharmaceutically acceptable salts thereof, wherein Z is a saturated or unsaturated 3 to 6 carbon chain, m is 2 or 3, R1 is a hydrogen atom, or a straight or branched C1-4 alkyl group,...
12/02/1997
5637700Purification of caprolactam
Caprolactam is purified by oxidative treatment in which mixtures which essentially contain the caprolactam to be purified and unsaturated lactams are treated with oxygen or an oxygen-containing gas mixture in an alkaline medium....
06/10/1997
5637701Process for preparing optically active amide derivatives
A novel asymmetric synthesis is provided for preparing optically active amides of formula (A) and their salts. ##STR1## In the formula, X represent --N-- or --CH--, R represents a mono or bicyclic aryl or heteroaryl group, R1 is an aryl or...
06/10/1997
5627283Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants
Amidinophenylalanine derivatives of the formula I ##STR1## the synthesis of these compounds, the use thereof and pharmaceutical agents which contain these compounds are described....
05/06/1997
1          
 
Sign InRegister
Username  
Password   
forgot password?